Skip to main content
. 2021 Oct 15;8:727412. doi: 10.3389/fmed.2021.727412

Table 1.

Patient demographics for serum and colonic biopsy samples.

Sex: n (%) Smoking
Diagnosis Male Female Mean age (SD) Yes n (%) No n (%) Unknown n (%)
Serum Control (n = 23) 5 (22) 18 (78) 58.3 (18.3) 4 (17) 17 (74) 2 (9)
Active LC (n = 14) 1 (7) 13 (93) 59.1 (17.5) 2 (14) 11 (79) 1 (7)
Active CC (n = 21) 4 (19) 17 (81) 58.8 (16.7) 7 (33) 13 (62) 1 (5)
CC remission (n = 15) 4 (27) 11 (73) 55.7 (16.5) 5 (33) 10 (67) 0 (0)
Colonic biopsies Control (n = 36) 20 (56) 16 (44) 60.0 (17.6) 8 (22) 18 (50) 10 (28)
Diarrhea control (n = 22) 6 (27) 16 (73) 47.2 (17.9) 7 (32) 9 (41) 6 (27)
Active LC (n = 9) 0 (0) 9 (100) 66.6 (8.2) 2 (22) 5 (56) 2 (22)
LC-HR (n = 6) 0 (0) 6 (100) 56.7 (26.5) 2 (33) 4 (67) 0 (0)
Active CC (n = 16) 2 (12.5) 14 (87.5) 56.2 (11.5) 4 (25.0) 10 (62.5) 2 (12.5)
CC-HR (n = 6) 0 (0) 6 (100) 60.2 (9.0) 3 (50) 3 (50) 0 (0)
Active UC (n = 15) 11 (73) 4 (27) 52.1 (15.5) 0 (0) 14 (93) 1 (7)
UC remission (n = 12) 7 (58) 5 (42) 61.4 (9.0) 0 (0) 8 (67) 4 (33)

LC, lymphocytic colitis; LC-HR, lymphocytic colitis in histological remission; CC, collagenous colitis; CC-HR, collagenous colitis in histological remission; UC, ulcerative colitis.